Consumption of antithrombin in patients suffering from severe COVID-19-infections

The goal of this application is to analyze the role of beta antithrombin in the hyperinflammation phase of COVID-19 patients.

Patients suffering from severe COVID-19 often experience symptoms of coagulopathy. The identification of coagulation factors that are involved in causing these complications may be of use for the development of novel therapeutic approaches against COVID-19.